Covid-19 Australia: War of words erupts between Ray Hadley and Alan Jones over Sydney Covid lockdown dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Australia s return to normal after Covid-19 depends on how quickly the nation gets vaccinated.
However, a small but noisy group of anti-vaxxers is trying to hold the country back by spreading myths about the vaccines.
They include concerns the jabs will alter DNA, cause infertility or even connect people to the internet.
Some also claim the vaccines are still on trial until 2023 - but actually it is normal for them to be monitored for a few years after approval.
Here Daily Mail Australia publishes official Department of Health advice to help you sift the fact from the fiction.
Are Covid-19 vaccines still on trial until 2023?
Novavax COVID-19 vaccine in Australia: When will we get it? And is it better than Pfizer?
Posted 3
updated 2
Novavax has begun its process of seeking TGA approval.
(
Print text only
Cancel
Key points:
It s one of four COVID-19 vaccines in the TGA pipeline
Novavax is made using more traditional-style methods and is currently going through phase three trials in the US and Mexico
Up until that moment, most Australians were slated to receive the AstraZeneca vaccine with 53.8 million doses already secured by the federal government.
But what about Novavax?
SARS-CoV-2, the virus which causes COVID-19 disease, has spike proteins.
Pfizer, AstraZeneca and Novavax vaccines all work by training the immune system to recognise and fight these spike proteins, but they each use different technologies to do this.
Australia will not achieve herd immunity by relying on the AstraZeneca Covid-19 vaccine, experts have warned, leaving the country at risk of rolling coronavirus epidemics that will prevent us from returning to normal life.
The government has ordered 53.8 million doses of the vaccine developed with Oxford University, with jabs set to be administered from March.
Chief Medical Officer Paul Kelly declared there will be enough jabs to vaccinate the entire population of Australia twice .
But doctors are concerned the nation is short-changing itself by leaning too heavily on the AstraZeneca option in its coronavirus response.
Trials show the vaccine has a much lower efficacy than the Pfizer and Moderna jabs already in use in countries including the United Kingdom and United States.